Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study

Auger-emitting radionuclides, exemplified by Pd-103, exhibit considerable therapeutic potential in cancer treatment due to their high cytotoxicity and localized biological impact. Despite these advantages, the separation of such radionuclides presents a complicated challenge, requiring intricate and...

Full description

Bibliographic Details
Main Authors: Aicha Nour Laouameria, Mátyás Hunyadi, Attila Csík, Zoltán Szűcs
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/17/2/253
_version_ 1797297284325572608
author Aicha Nour Laouameria
Mátyás Hunyadi
Attila Csík
Zoltán Szűcs
author_facet Aicha Nour Laouameria
Mátyás Hunyadi
Attila Csík
Zoltán Szűcs
author_sort Aicha Nour Laouameria
collection DOAJ
description Auger-emitting radionuclides, exemplified by Pd-103, exhibit considerable therapeutic potential in cancer treatment due to their high cytotoxicity and localized biological impact. Despite these advantages, the separation of such radionuclides presents a complicated challenge, requiring intricate and time-intensive “wet chemistry” methods attributed to the exceptional chemical inertness of the associated metals. This study proposes an innovative solution to this separation challenge through the design and implementation of a piece of radionuclide separation equipment (RSE). The equipment employs a dry distillation approach, capitalizing on differences in partial vapor pressures between irradiated and resulting radioactive metals, with a diffusion-driven extraction method applied to separate Pd-103 radionuclides generated via the proton irradiation of Rh-103 at cyclotron. Our optimization endeavors focused on determining the optimal temperature for effective metal separation and adjusting the diffusion, evaporation, and deposition rates, as well as addressing chemical impurities. The calculations indicate 17% ± 2% separation efficiency with our RSE. Approximately 77 ± 2% and 49 ± 2% of the deposited Pd-103 were isolated on substrates of Nb foil and ZnO-covered W disc, respectively. The proposed innovative dry distillation method that has been experimentally tested offers a promising alternative to conventional separation techniques, enabling enhanced purity and cost-efficient cancer treatment strategies.
first_indexed 2024-03-07T22:18:08Z
format Article
id doaj.art-a35865be03c946ca9de521612e9cd667
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-07T22:18:08Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-a35865be03c946ca9de521612e9cd6672024-02-23T15:30:51ZengMDPI AGPharmaceuticals1424-82472024-02-0117225310.3390/ph17020253Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept StudyAicha Nour Laouameria0Mátyás Hunyadi1Attila Csík2Zoltán Szűcs3Doctoral School of Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, HungaryHUN-REN Institute for Nuclear Research, Bem tér 18/c, 4026 Debrecen, HungaryHUN-REN Institute for Nuclear Research, Bem tér 18/c, 4026 Debrecen, HungaryHUN-REN Institute for Nuclear Research, Bem tér 18/c, 4026 Debrecen, HungaryAuger-emitting radionuclides, exemplified by Pd-103, exhibit considerable therapeutic potential in cancer treatment due to their high cytotoxicity and localized biological impact. Despite these advantages, the separation of such radionuclides presents a complicated challenge, requiring intricate and time-intensive “wet chemistry” methods attributed to the exceptional chemical inertness of the associated metals. This study proposes an innovative solution to this separation challenge through the design and implementation of a piece of radionuclide separation equipment (RSE). The equipment employs a dry distillation approach, capitalizing on differences in partial vapor pressures between irradiated and resulting radioactive metals, with a diffusion-driven extraction method applied to separate Pd-103 radionuclides generated via the proton irradiation of Rh-103 at cyclotron. Our optimization endeavors focused on determining the optimal temperature for effective metal separation and adjusting the diffusion, evaporation, and deposition rates, as well as addressing chemical impurities. The calculations indicate 17% ± 2% separation efficiency with our RSE. Approximately 77 ± 2% and 49 ± 2% of the deposited Pd-103 were isolated on substrates of Nb foil and ZnO-covered W disc, respectively. The proposed innovative dry distillation method that has been experimentally tested offers a promising alternative to conventional separation techniques, enabling enhanced purity and cost-efficient cancer treatment strategies.https://www.mdpi.com/1424-8247/17/2/253Auger electron therapypalladium-103partial pressureradioisotope separationdiffusion
spellingShingle Aicha Nour Laouameria
Mátyás Hunyadi
Attila Csík
Zoltán Szűcs
Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study
Pharmaceuticals
Auger electron therapy
palladium-103
partial pressure
radioisotope separation
diffusion
title Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study
title_full Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study
title_fullStr Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study
title_full_unstemmed Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study
title_short Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study
title_sort innovative approach to producing palladium 103 for auger emitting radionuclide therapy a proof of concept study
topic Auger electron therapy
palladium-103
partial pressure
radioisotope separation
diffusion
url https://www.mdpi.com/1424-8247/17/2/253
work_keys_str_mv AT aichanourlaouameria innovativeapproachtoproducingpalladium103foraugeremittingradionuclidetherapyaproofofconceptstudy
AT matyashunyadi innovativeapproachtoproducingpalladium103foraugeremittingradionuclidetherapyaproofofconceptstudy
AT attilacsik innovativeapproachtoproducingpalladium103foraugeremittingradionuclidetherapyaproofofconceptstudy
AT zoltanszucs innovativeapproachtoproducingpalladium103foraugeremittingradionuclidetherapyaproofofconceptstudy